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Abstract A deficiency of GTP cyclohydrolase, encoded by
the GCH1 gene, results in two neurological diseases: hyper-
phenylalaninaemia type HPABH4B and DOPA-responsive
dystonia. Genes involved in neurotransmitter metabolism
and motor systems may contribute to palatogenesis. The pur-
pose of the study was to analyse polymorphic variants of the
GCH1 gene as risk factors for non-syndromic cleft lip with or
without cleft palate (NSCL/P). Genotyping of nine polymor-
phisms was conducted in a group of 281 NSCL/P patients and
574 controls. The GCH1 variant rs17128077 was associated
with a 1.7-fold higher risk for NSCL/P (95 %CI=1.224–
2.325; p=0.001). We also found a significant correlation be-
tween the rs8004018 and rs17128050 variants and an in-
creased risk of oral clefts (ptrend=0.003 and 0.004, respective-
ly). The best evidence of the global haplotype association was
observed for rs17128050 and rs8004018 (pcorr=0.0152). This
study demonstrates that the risk of NSCL/P is associated with
variants of the GCH1 gene related to BH4 metabolism and
provides some evidence of the relationships between
morphological/functional shifts in the central nervous system
and orofacial clefts.
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Non-syndromic cleft lip with or without cleft palate
(NSCL/P, OMIM 119530) is a common birth defect in
humans, with an approximate prevalence of 4 to 13 per
10,000 live births, and is notable for its significant life-
long morbidity and complex aetiology with both genetic
and environmental factors contributing to the condition
[1–3]. Moreover, approximately 12 % of all embryos or
foetuses aborted have an orofacial cleft [4]. Well-known
candidate genes that are correlated with the risk of
NSCL/P in various populations include IRF6, VAX1,
MAFB, NOG, ARGHAP29, and the 8q24.21 locus (gene
desert) [1, 2]. However, their nucleotide variants do not
account for all observed NSCL/P cases, emphasising the
need for identifying new genetic factors associated with
orofacial clefts [2]. There is uncertainty about the indi-
vidual variability in response to surgery and rehabilita-
tion in NSCL/P-affected patients as well as the validity
of the theories that have determined the selection of
some techniques over others [5, 6]. Increasing evidence
suggests that genetic loci involved in a pathological
facial trait contribute significantly to the variation of
normal facial morphology and may be associated with
the differences in treatment responses of individual
NSCL/P patients [7].
Several reports have provided evidence that brain morphol-
ogy is fundamentally altered in at least some portion of the
NSCL/P population [8, 9]. This co-occurrence reflects the
intimate developmental relationship between the face and
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the brain. For several decades, it has been known that the
ingestion of certain poisonous plants from the Conium,
Lupinus, and Nicotiana genera, which contain piperidine al-
kaloids, during critical periods of gestation induces cleft palate
in sheep, goats, cattle, and pigs [10]. Panter et al. [11] demon-
strated that piperidine alkaloids induce a reduction in foetal
movement that is directly responsible for abnormal
palatogenesis in livestock. Gamma amino butyric acid
(GABA) is synthesised from glutamate by glutamic acid de-
carboxylase (GAD). Vesicular inhibitory amino acid trans-
porter (VIAAT) is responsible for the storage of GABA. Gam-
ma amino butyric acid subunit beta-3 receptors are encoded
by the GABRB3 gene and are major inhibitory neurotransmit-
ter receptors in the central nervous system [12, 13]. In 2010, a
study using knockout mice revealed that cleft palate may be
the result of alternations in GABA signalling, due to the loss
of Gad1 and Viaat gene functions within the central nervous
system during embryogenesis, which clinically manifests as a
loss of normal foetal movements [12]. The lack of the Viaat
expression in the palate suggests that its function is not re-
quired in the palate for normal palatogenesis [12]. Interesting-
ly, there is evidence for an association between single nucle-
otide polymorphisms (SNPs) in GABRB3 and GAD67,
encoding isoform of GAD and a risk for NSCL/P [11, 13, 14].
6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4) is synthe-
sised de novo from guanosine triphosphate (GTP) through the
catalysis of three enzymatic reactions by GTP cyclohydrolase
(rate-limiting step), 6-pyruvoytetrahydrobiopterin synthase,
and sepiapterin reductase [15]. GTP cyclohydrolase deficiency
results in two neurological disorders: hyperphenylalaninaemia
with absent urinary neopterin and biopterin (HPABH4B) and
dihydroxyphenylalanine (DOPA)-responsive dystonia
(DYT5a, also known as Segawa’s disease) with reduced CSF
levels of total biopterin (of which BH4 is the main component)
and neopterin. DYT5a is caused by a particular impairment of
nigrostriatal dopamine neurons that are different from those
involved in Parkinson’s disease and is a childhood-onset or
adolescent-onset form of dystonia [15]. Diurnal fluctuation
of dystonia with increasing severity over the course of
the day is a common feature [15, 16]. There is usually
gradual generalisation of symptoms with age. Patients
with DOPA-responsive dystonia have sufficient BH4
stores to metabolise a normal intake of phenylalanine
[16]. A recent study conducted by Lupo et al. [17]
suggested an association between a polymorphic varia-
tion of the GCH1 gene (OMIM *2643), encoding GTP
cyclohydrolase, and abnormal neural tube closure.
Such findings have prompted the search for oral cleft-
associated variants of genes involved in neurotransmitter me-
tabolism and motor systems. Therefore, the present study was
designed to evaluate whether common nucleotide variations




Peripheral blood samples from 281 unrelated subjects with
NSCL/P were obtained from the Department of Paediatrics
and Paediatric Surgery at the Institute of Mother and Child
in Warsaw, from the Department of Plastic Surgery Special-
ist Medical Center in Polanica Zdroj, and from the Depart-
ment of Jaw Orthopaedics at the Medical University of Lu-
blin. Eligibility was ascertained from detailed medical re-
cords. The non-syndromic designation was based on a di-
agnosis of isolated CL/P with no other apparent cognitive
and structural anomalies. The control group consisted of
574 healthy, non-related individuals with no family history
of clefts or other major congenital structural anomalies,
whom were mostly patients attending local primary care
paediatricians and general practitioners. All participants
were Caucasians of Polish origin. DNA was isolated from
peripheral blood lymphocytes by a salting-out extraction
procedure. The experiments were approved by the local
Ethics Committee at the Poznan University of Medical Sci-
ences. Written and oral consent were obtained from the
legal guardians of all of the participants.
Single Nucleotide Polymorphism Selection
and Genotyping
Single nucleotide polymorphisms (SNPs) in the GCH1
gene were identified from the related literature, from the
dbSNP database (http://www.ncbi.nlm.nih.gov/projects/
SNP/), and with the use of genome browsers of the
International HapMap Project (http://www.hapmap.org/
index .h tml .en) and 1000 genomes (h t tp : / /www.
1000genomes.org/). A final set of nine SNPs (Table 1) were
selected based on the following criteria: location within
protein coding or putative regulatory regions, haplotype-
tagging properties, and minor allele frequency (MAF) of
at least 10 % in the Caucasian population. The linkage dis-
equilibrium (LD) patterns and the structure of haplotype
blocks across each gene were determined using genotype
data from the HapMap database and the Haploview 4.0
software package (http://www.broad.mit.edu/mpg/
haploview/).
Genotyping of nucleotide variants rs841, rs17128050,
rs8004018, and rs17128077 was carried out on the
LightCycler 480 system (Roche Diagnostics, Mannheim,
Germany) using pre-designed and custom TaqMan SNP
Genotyping Assays according to the manufacturer’s in-
structions provided by Applied Biosystems (Applied
Biosystems, Foster City, CA). The genotypes were called
using the endpoint genotyping LightCycler 480 Software
version 1.5. The genotyping of rs10483639, rs4411417,
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rs3759664, and rs8007267 was carried out by high-
resolut ion melt ing curve analysis (HRM ) on the
LightCycler 480 system. The analysis of rs3783641 was
conducted by the digestion of the amplified PCR products
with the BsrI restriction enzyme (PCR-RFLP). Primer se-
quences and genotyping conditions are available on re-
quest. For quality control, approximately 10 % of the ran-
domly chosen samples were re-genotyped. Samples that
failed genotyping were not repeated and were removed
from statistical calculations.
Statistical Analysis
For each SNP, Hardy-Weinberg (HW) equilibrium was
evaluated in both patients and controls by the chi-square
(χ2) test. Statistically significant deviation from HW expec-
tations was interpreted as a p value<0.05. The differences
in allele and genotype frequencies between cases and con-
trols were determined using standard χ2 and Fisher exact
tests. SNPs were tested for an association with NSCL/P
using the Cochran-Armitage trend test. Odds ratios (ORs)
with 95 % confidence intervals (95 %CIs) were used to
assess the strength of the association. The dominant and
recessive models were analysed. The Bonferroni correction
was used to correct for multiple testing, and the p values<
0.0056 (0.05/9 SNPs) were interpreted as statistically sig-
nificant. The haplotype-based association analysis was per-
formed using PLINK v1.07 (http://pngu.mgh.harvard.edu/
~purcell/plink/). The omnibus haplotype test (jointly
estimating all haplotype effects at a location) for sliding
windows of two to four SNPs across the gene was
conducted using logistic regression. Significant p values
were corrected using the 10,000-fold permutation test.
Results
Single-Marker Association Analysis
None of the tested polymorphisms showed evidence of devi-
ation from HW equilibrium in either cases or controls (p-
values>0.05). The MAF for all SNPs was at least 11 %.
The genotyping results, OR, and 95 %CI calculations for nine
SNPs of the GCH1 gene are reported in Table 2. Statistical
analysis revealed a significant association between polymor-
phic variants of GCH1 and an increased risk of NSCL/P
(Table 2). The allelic and genotyping frequencies of
rs17128077 were significantly different between NSCL/P pa-
tients and controls (pgenotypic=0.005 and pallelic=0.001). The
ptrend value for this SNP was 0.001. The OR for individuals
with the rs17128077 T allele (TC or TT) compared to CC
homozygotes was 1.687 (95 %CI=1.224–2.325; p=0.001).
This result was statistically significant even after multiple test-
ing corrections. Under the assumption of a dominant model,
the calculated ORs for GCH1 rs8004018 and rs17128050
were 1.604 (95 %CI=1.154–2.229; p=0.005) and 1.559
(95 %CI=1.121–2.167; p=0.008), respectively. These two
SNPs were in complete LD with each other (r2=1.00) and in
moderate LDwith rs17128077 (r2=0.60) (Table 3, Fig. 1). For
the remaining analysed GCH1 SNPs, there was no evidence
for both allelic and genotypic associations with the risk of oral
clefts (Table 2).
Haplotype Association Analysis
Three two-SNP haplotypes (rs17128050-rs8004018,
rs8004018-rs3783641, and rs8007267-rs17128077), one
three-SNP haplotype (rs3759664-rs8007267-rs17128077),
and two four-SNP haplotypes (rs10483639-rs841-
Table 1 Characteristics of
polymorphisms analysed in the
GCH1 gene
rs no. Chromosomal positiona SNP function Allelesb MAF
rs10483639 chr14:55306457 N/A C/G (FWD) 0.19
rs841 chr14:55310492 UTR-3 C/T (REV) 0.18
rs4411417 chr14:55320563 intron C/T (FWD) 0.19
rs17128050 chr14:55343879 intron C/T (FWD) 0.11
rs8004018 chr14:55350696 intron A/G (FWD) 0.11
rs3783641 chr14:55360139 intron A/T (FWD) 0.19
rs3759664 chr14:55371579 nearGene-5 C/T (FWD) 0.17
rs8007267 chr14:55378991 N/A C/T (FWD) 0.17
rs17128077 chr14:55386034 N/A C/T (FWD) 0.12
MAF minor allele frequency calculated from the control samples, FWD forward, REV revers
a According to the February 2009 human reference sequence (GRCh37)
b According to the Single Nucleotide Polymorphism database (dbSNP), underline denotes the minor allele in the
control samples
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rs4411417-rs17128050 and rs4411417-rs17128050-
rs8004018-rs3783641) were associated with NSCL/P after
permutation correction (Table 4). All of these haplotype com-
binations include nucleotide variants (rs17128050,
rs8004018, and rs17128077) that were associated with the risk
of NSCL/P in the single SNP association tests (Table 2). The
best evidence of global haplotype association was observed
for rs17128050 and rs8004018 (pcorr=0.0152).
Discussion
Although great advances have been achieved in candidate
gene identification for NSCL/P, the underlying molecular
mechanisms remain obscure [1–3, 18]. Identifying the under-
lying aetiology is crucial for improving prevention strategies
and genetic risk counselling. Recent experimental findings
point toward at least some interaction between abnormal foe-
tal movement and NSCL/P [12]. In this study, we assessed
whether polymorphic variants in the GCH1 gene, in which
mutations may cause dystonia, are associated with NSCL/P
in a sample from the Polish population. Our results suggest
that the presence of the GCH1 rs17128077 T allele is associ-
ated with a 1.7-fold increased risk for NSCL/P in the investi-
gated population. We also found a significant correlation
between the rs8004018 and rs17128050 variants with an in-
creased risk for oral clefts. The association with single SNPs
was confirmed at the haplotype level. We showed that two-,
three-, and four-SNP haplotypes were associated with a risk
for NSCL/P even after multiple testing corrections. To our
knowledge, this is the first report evaluating the clinical im-
pact of the GCH1 rs17128077 variant. The interpretation of
SNP results is especially challenging in complex disorders. It
is unknown how these SNPs affect the gene expression level
or the function of the encoded protein. In addition, there is no
data showing the effect of analysed GCH1 variants on the
level of BH4 and total biopterins. Therefore, further in vitro
and in vivo functional studies are needed to characterise the
functional significance of these SNPs. The observed strong
association between these SNPs and a risk for NSCL/P might
be a result of complete or incomplete linkage disequilibrium
with one or more yet-unknown functional variants of the
GCH1 gene. It is worth noting that the GCH1 expression
was detected in multipotent, proliferative human neural crest
cells [19].
In 2006, Tegeder et al. [20] reported that among individuals
with the haplotype consisting of the minor alleles rs10483639,
rs3783641, and rs8007267 (C-A-T), the GCH1 mRNA levels
were lower compared with other haplotypes. According to
Zhang et al. [21], rs841 also affects the expression of GCH1.
In addition, the excess production of BH4 is closely correlated
with increased pain sensitivity [22–24]. In our study, the SNPs
rs10483639, rs3783641, rs8007267, rs4411417, and rs841,
which have been previously reported as conferring pain sus-
ceptibility, showed no association with the risk of NSCL/P
[22–25]. The study conducted by Kim and Dionne [22] re-
vealed no contribution of SNPs rs8004018 and rs17128050,
rs8007267, rs3783641, rs841, rs10483639, or rs4411417 to
pain sensitivity during the removal of the third molar teeth.
The GCH1 rs841 variant is reported to be associated with
mildly increased blood pressure and heart rate [21] and serves
as an independent predictor of deleterious long-term outcomes
in ischemic stroke [26]. However, there are unfortunately no
studies assessing the association between SNPs in the GCH1
gene with pain or cardiovascular risk in the Polish population.
BH4 is an essential cofactor for three aromatic amino acid
hydroxylases, including tyrosine hydroxylase (rate-limiting
enzyme in dopamine biosynthesis), tryptophan hydroxylase
(TPH2), and phenylalanine hydroxylase (PAH), as well as
three isoforms of nitric oxide synthase (NOS), which catalyses
the synthesis of nitric oxide from arginine, and alkylglycerol
monooxygenase. Interestingly, in our previous studies, we
showed that polymorphic variants of PAH and TPH2 as well
as haplotype combinations of the TPH2 SNPs were signifi-
cantly correlated with NSCL/P in the Polish population [27,
28]. Several studies have observed orofacial clefting and
midfacial hypoplasia in offspring of women with untreated
hyperphenylalaninemia [29]. In addition, abnormal results of
GCH1
r2
chr14: 54376207 - 54455784
Fig. 1 The linkage disequilibrium (LD) plot of SNPs analysed within the
GCH1 gene. The plot was generated using the genotype data from control
samples and the Haploview 4.0 software (Broad Institute, Cambridge,
MA). The names of SNPs significantly correlated with the risk of
NSCL/P are enclosed in boxes. Numbers represent r2 values expressed
as a percentage of maximal value (1.0). Squares without numbers corre-
spond to r2=1.0. A black-to-white gradient shows highest (1.0) to lowest
(0.0) r2 value
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orally administered phenylalanine loading tests in mothers of
children with orofacial clefts and increased phenylalanine
urine excretion in NSCL/P children were reported [30, 31].
Moreover, we have also demonstrated moderate evidence for
the association of polymorphic variants of genes related to
arginine metabolism (ASS1, SLC25A13) with abnormal
palatogenesis [32]. The NOS3 variants were reported to be
associated with NSCL/P risk in a USA population [33].
Both the craniofacial region and neural tube arise from
neural crest cells, leading to the hypothesis that there is a
shared genetic background for orofacial clefts and spina
bifida. In contrast to these expectations, in our study, the allele
and genotype distributions of the three polymorphic variants
ofGCH1 regarded as linkedwith spina bifida risk (rs8007267,
rs3783641, rs10483639) [17] were found to be similar among
NSCL/P affected children and controls. The haplotype
rs8007267-rs3783641-rs10483639 was not associated with
the risk of oral clefts; however, we identified three other hap-
lotype combinations, including those variants separately that
appeared to influence NSCL/P risk.
TheGCH1 gene has been studied in terms of its association
with psychiatric disorders and cognitive function. Interesting-
ly, an increased occurrence of autism has been observed in
patients with NSCL/P [34]. Young children with autism dem-
onstrate a reduced concentration of BH4 in cerebrospinal flu-
id, and treatment with this cofactor represents a novel therapy
for autism spectrum disorders [35]. Schnetz-Boutaud et al.
[36] genotyped four SNPs in GCH1, including one polymor-
phic variant analysed in our study (rs3783641), and observed
no association in a dataset of 403 Caucasian families with
autistic individuals. However, in this study, two SNPs of the
gene encoding 6-pyruvoytetrahydrobiopterin synthase (PTS)
showed a statistically significant association with autism [36].
In addition, there are also reports on the association of rs841
with personality traits: The rs841 CC homozygous male sub-
jects had higher scores of novelty seeking, C allele carriers
with chronic fatigue syndrome had higher scores for harm
avoidance, and TT homozygotes had lower attention function
[37].
We must note that the number of selected polymorphisms
in the present study does not cover the complete GCH1 gene.
Allele frequencies are known to vary among different popu-
lations and different ethnic backgrounds. Because our study
was conducted only in the Polish population, which is known
to be ethnically homogenous, the results should be extrapolat-
ed to other ethnic groups cautiously. This study identified the
Table 4 Haplotype analysis of polymorphisms located in the GCH1 gene
Number of SNPs Haplotype combination Chromosomal positiona p value Corrected p valueb
2 rs10483639_rs841 55306457–55310492 0.764 0.999
2 rs841_rs4411417 55310492–55320563 0.886 1.000
2 rs4411417_rs17128050 55320563–55343879 0.016 0.079
2 rs17128050_rs8004018 55343879–55350696 0.003 0.015
2 rs8004018_rs3783641 55350696–55360139 0.008 0.039
2 rs3783641_rs3759664 55360139–55371579 0.843 1.000
2 rs3759664_rs8007267 55371579–55378991 0.841 1.000
2 rs8007267_rs17128077 55378991–55386034 0.005 0.025
3 rs10483639_rs841_rs4411417 55306457–55320563 0.778 0.999
3 rs841_rs4411417_rs17128050 55310492–55343879 0.014 0.066
3 rs4411417_rs17128050_rs8004018 55320563–55350696 0.013 0.061
3 rs17128050_rs8004018_rs3783641 55343879–55360139 0.012 0.058
3 rs8004018_rs3783641_rs3759664 55350696–55371579 0.020 0.095
3 rs3783641_rs3759664_rs8007267 55360139–55378991 0.857 1.000
3 rs3759664_rs8007267_rs17128077 55371579–55386034 0.006 0.028
4 rs10483639_rs841_rs4411417_rs17128050 55306457–55343879 0.010 0.045
4 rs841_rs4411417_rs17128050_rs8004018 55310492–55350696 0.013 0.063
4 rs4411417_rs17128050_rs8004018_rs3783641 55320563–55360139 0.010 0.049
4 rs17128050_rs8004018_rs3783641_rs3759664 55343879–55371579 0.026 0.119
4 rs8004018_rs3783641_rs3759664_rs8007267 55350696–55378991 0.021 0.098
4 rs3783641_rs3759664_rs8007267_rs17128077 55360139–55386034 0.015 0.074
Statistically significant results are highlighted in bold font
a According to the February 2009 human reference sequence (GRCh37)
b p value calculated using permutation test and a total of 10,000 permutations
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association of polymorphisms with risk for NSCL/P without
any attempt to establish a cause-and-effect relationship.
The GCH1 gene appears to be highly mutable. To date,
there are 138 reported different mutations/deletions associ-
ated with the phenotype DYT5a (http://www.biopku.org/
biomdb/home.asp; Blau N, Thony B, accessed 6/11/
2014). Most cases of Segawa’s disease present with the
autosomal dominant form, but autosomal recessive
mutations in GCH1 have also been reported. The reason
why such a variety of mutations occur in GCH1 remains
unknown. A wide range of neurological manifestations in
patients with identical GCH1 mutations is a well-known
feature of DYT5a. It has been shown that NSCL/P is most
often left-sided [1, 38]. It is noteworthy that DOPA-
responsive dystonia during onset demonstrates a preference
to the left side [16]. In addition, the coexistence of DOPA-
unresponsive dystonia and cleft lip and palate in patients
with Baraitser-Winter cerebrofrontofacial syndrome
(BWCFF) was described [39]. BWCFF shows variable
CNS involvement. Structurally, patients may have a normal
brain or some degree of pachygyria with anteroposterior
severity gradient [39]. The results of the present study,
while by no means definitive, provide some evidence
supporting earlier observations that orofacial clefts may
be the result of alternations in the motor system during
embryogenesis [12]. At present, the generalisability of the-
se findings is uncertain, primarily due to the small sample
size available and the lack of data on the neurological status
of participants and their families. However, the complexity
of embryogenesis leads us to hypothesise that a shift in the
amount or the timing of expression of a single gene, such as
GCH1, could affect multiple pathways and that the
resulting phenotype may be influenced by common and
rare genetic variants in this pathways.
In summary, we provide evidence for the role of GCH1
nucleotide variants in the aetiology of NSCL/P in the Polish
population. The traditional view has been that almost all be-
havioural deficits in individuals with NSCL/P are secondary
manifestations of hearing and speech problems. The results of
our study suggest that these deficits may stem also from direct
relationships between morphological/functional shifts in the
central nervous system and orofacial clefts. The factors
suspected to be associated with the changes are polymorphic
variants in the genes involved in neurotransmitters homeosta-
sis and motor systems [11–14]. Additional association studies
conducted in different populations as well as functional stud-
ies in appropriate model systems are needed to confirm our
results and to explore the role of GCH1 in craniofacial
development.
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